ListarBioquímica Médica y Biología Molecular e Inmunología por materia "Chemotherapy"
Mostrando ítems 1-1 de 1
-
Artículo
Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study
(BMC, 2023)Background: We evaluated a new chemoimmunotherapy combination based on the anti-PD1 monoclonal antibody pembrolizumab and ...